StonvexLoading…
StonvexStonvexStonvexCore line items from KYMR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $34.37M | $39.21M | $36.34M | $33.58M |
Operating Income | $-84.15M | $-349.40M | $-251.50M | $-158.98M |
Net Income | $-69.23M | $-311.35M | $-224.37M | $-142.19M |
EPS (Diluted) | $-0.71 | $-3.69 | $-2.71 | $-1.77 |
Total Assets | $1.67B | $1.74B | $1.10B | $1.13B |
Total Liabilities | $129.38M | $163.15M | $155.79M | $159.59M |
Cash & Equivalents | $144.09M | $357.01M | $112.95M | $335.82M |
Free Cash Flow OCF − CapEx | $-89.27M | $-234.34M | $-167.49M | $-140.20M |
Shares Outstanding | 82.18M | 81.32M | 71.74M | 70.56M |